Skip to content

📊 Phase 2: Today's Opportunities (Oct 14, 2025)

Research Date: October 14, 2025 Strategy: Hybrid (70% Momentum | 20% Leveraged | 10% Micro-Cap) Target Deployment: $10k-$20k over 2 weeks

🚀 Category 1: Momentum Plays (70% - Top Picks)

Sector Analysis:

✅ Technology/AI: Strongest sector in 2025 (+13.7% S&P 500 YTD) ✅ Semiconductors: Top performer - AI chip demand driving growth ✅ Market Context: Fed rate cuts supportive, AI boom continues

Top Momentum Stock Candidates:

1. NVDA - Nvidia (Your Winner Formula!)

  • Current Status: YOU ALREADY OWN! (+55%, protected with trailing stop)
  • Sector: Semiconductors / AI chips
  • Momentum: Leading AI infrastructure play
  • Action: HOLD with trailing stop, don't add (already exposed)

2. AVGO - Broadcom

  • Why: Best-performing semiconductor stock October 2025
  • Catalyst: AI infrastructure, data center chips
  • Similar to: NVDA (semiconductors)
  • Position Size: $2,000-$3,000
  • Entry Strategy: On pullback to support
  • Risk: Tech sector concentration if you also have NVDA

3. AMD - Advanced Micro Devices

  • Why: NVDA competitor, AI chip demand
  • Catalyst: Market share gains, data center growth
  • Position Size: $1,500-$2,000
  • Entry Strategy: Above $165, below $175
  • Stop: 3x ATR or -8% to -10%

4. TSM - Taiwan Semiconductor

  • Why: Manufactures chips for Apple, NVDA, AMD
  • Diversification: Different angle on chip demand
  • Position Size: $2,000
  • Entry Strategy: On any pullback
  • Lower Volatility: More stable than pure AI plays

5. AAPL / GOOGL / MSFT (Mega-Cap Tech)

  • Why: AI integration, strong momentum
  • Benefit: Less volatile than pure AI plays
  • Position Size: $2,000-$3,000 each
  • Entry: On minor pullbacks (they're at/near highs)

Conservative ($6k): - AVGO: $2,000 - TSM: $2,000 - AAPL or MSFT: $2,000

Aggressive ($12k): - AVGO: $3,000 - AMD: $2,500 - TSM: $2,500 - MSFT: $2,000 - GOOGL: $2,000

📈 Category 2: Leveraged ETFs (20% - Top Picks)

Analysis:

  • LABU (+27%): YOU ALREADY OWN - Working perfectly!
  • Semiconductors: Still hot (SOXL candidate)
  • Tech Broad: Strong momentum (TQQQ, TECL)

Top Leveraged ETF Candidates:

1. SOXL - 3x Semiconductors

  • Why: Semiconductors = #1 performing sector Oct 2025
  • Benefit: 3x exposure to NVDA/AMD/AVGO sector
  • Risk: High volatility, 3x leverage
  • Position Size: $2,000
  • Stop: 7% trailing (tighter due to leverage)
  • Entry: Confirm semiconductor uptrend continues

2. TQQQ - 3x NASDAQ-100

  • Why: Broad tech exposure, less concentrated than SOXL
  • Benefit: Diversified across AAPL, MSFT, NVDA, etc.
  • Position Size: $2,000
  • Stop: 7% trailing
  • Entry: On NASDAQ strength confirmation

3. LABU - 3x Biotech (You already own!)

  • Current: +27%, protected with 9% trailing stop
  • Action: HOLD, consider adding $1k-$2k if biotech continues strong
  • Don't: Over-concentrate in one leveraged ETF

Option A (Diversify): - SOXL: $2,000 (semiconductors) - Keep LABU as is (biotech) - Total: $2k new + existing LABU

Option B (Add to Winner): - LABU: Add $2,000 (double down on what's working) - Total: $2k new, higher biotech concentration

Option C (Tech Focus): - TQQQ: $2,000 (broad tech) - Keep LABU as is - Total: $2k new, diversified sectors

My Recommendation: Option A (SOXL) - Semiconductors are THE hot sector right now

🎲 Category 3: Micro-Cap Catalysts (10% - Research Findings)

Fresh Catalyst Research:

Based on web search, here are upcoming biotech catalysts:

1. Moonlake Immunotherapeutics (Potential)

  • Catalyst: Phase 3 results for hidradenitis suppurativa
  • Timing: Expected Q4 2025 (likely November)
  • Market Cap: Need to verify (<$500M for micro-cap)
  • Action: Research further - get exact date

2. Vera Therapeutics (Potential)

  • Catalyst: IgA nephropathy study readout coming
  • Timing: Q4 2025
  • Drug: Atacicept
  • Action: Research market cap and exact readout date

3. Savara (Potential)

  • Catalyst: IMPALA-2 Phase 3 results for lung disease
  • Timing: Presenting at CHEST 2025 conference
  • Action: Verify if results already released or upcoming

Critical Issue: Need Specific Dates

The research found several Phase 3 catalysts but didn't provide exact dates or confirm micro-cap status (<$500M market cap).

Next Steps for Micro-Caps:

Option A: Deeper Research (I can help) - Look up each company's market cap - Find exact catalyst dates - Evaluate if timing is right (14-30 days ideal)

Option B: Skip for Now - Your LABU (+27%) already gives biotech exposure - Focus capital on proven momentum plays - Wait for clearer micro-cap catalyst opportunities

Option C: Manual Research (You do) - Visit BiopharmCatalyst.com directly - Filter: Next 30 days, Phase 3, market cap <$500M - Come back with 2-3 specific tickers

My Recommendation:

Option B (Skip micro-caps this week)

Reasoning: - FBIO just lost -24.6% (micro-cap risk is real) - Your momentum strategy WORKS (NVDA +55%) - LABU gives you biotech exposure already - Better to deploy more into proven strategies - Can add micro-caps later when clearer catalysts emerge

Immediate Actions (Next 2 hours):

Step 1: Paper Trading Setup

Deploy to Alpaca Paper TODAY:

  1. AVGO (Momentum #1)
  2. Check current price
  3. If reasonable (not extended), buy $1,000 in paper

  4. Set 9% stop

  5. SOXL (Leveraged #1)

  6. Buy $1,000 in paper
  7. Set 7% trailing stop

  8. Test the 3x semiconductor thesis

  9. TSM (Momentum #2)

  10. Buy $1,000 in paper
  11. Set 9% stop
  12. Diversification from pure AI plays

Total Paper Deployment TODAY: $3,000

Tomorrow Actions (Oct 15):

Monitor Paper Trades:

  • Check how AVGO, SOXL, TSM performed
  • Any red flags?
  • Thesis still valid?

Add More to Paper:

  • AMD: $1,000
  • MSFT or AAPL: $1,000

Total Paper by End of Day 2: $5,000

Week 1 Target (Oct 14-18):

  • Paper Account: $5k-$8k deployed
  • Positions: 4-6 stocks/ETFs
  • Goal: Validate which setups work
  • NO live deployment yet - all testing

Week 2 Target (Oct 21-27):

  • Move winners to LIVE: Pick best 2-3 from paper
  • Position sizes: $2k-$3k each live
  • Total live deployed: $6k-$10k
  • Keep trailing stops: Protect gains

📋 Summary: Your Phase 2 Game Plan

What to Deploy:

70% Momentum - Semiconductors & Tech: - AVGO, AMD, TSM (chips) - AAPL, MSFT, GOOGL (mega-cap tech)

20% Leveraged - Sector Momentum: - SOXL (3x semiconductors) - NEW - LABU (3x biotech) - KEEP existing

10% Micro-Caps - SKIP THIS WEEK: - Focus on proven strategies - Revisit when clearer catalysts - LABU gives biotech exposure

How to Deploy:

Week 1: Paper trade $5k-$8k (test everything) Week 2: Move winners to live $6k-$10k

Total Deployed End of Phase 2: $6k-$10k LIVE (validated in paper first)

✅ Your Immediate Next Step

Right now, you should:

  1. Open Alpaca Paper Trading Dashboard

  2. https://app.alpaca.markets/paper/dashboard

  3. Place These 3 Orders (Market or Limit):

  4. AVGO: Buy $1,000 worth
  5. SOXL: Buy $1,000 worth

  6. TSM: Buy $1,000 worth

  7. Set Stops:

  8. AVGO: 9% trailing stop
  9. SOXL: 7% trailing stop

  10. TSM: 9% trailing stop

  11. Come Back Tomorrow:

  12. Report how they performed
  13. We'll add 2 more positions

Time to complete: 15-20 minutes

Ready to execute? Let me know if you want help with: - Current prices for these tickers - Exact quantities to buy - Setting up the orders - Something else

What's your next move? 🚀